CD4 News and Research

RSS
Study offers localized treatment direction for a cause of Crohn's disease

Study offers localized treatment direction for a cause of Crohn's disease

Is non-severe SARS-CoV-2 infection characterized by early T cell proliferation?

Is non-severe SARS-CoV-2 infection characterized by early T cell proliferation?

Study suggests T-cells don't determine survival in severe COVID-19

Study suggests T-cells don't determine survival in severe COVID-19

New approach to CAR T gene therapy yields efficient and longer-lasting response against HIV

New approach to CAR T gene therapy yields efficient and longer-lasting response against HIV

Researchers develop a recombinant SARS-CoV-2 receptor-binding domain trimer vaccine candidate

Researchers develop a recombinant SARS-CoV-2 receptor-binding domain trimer vaccine candidate

Study of twins reveals differences in adaptive immunity towards SARS-CoV-2

Study of twins reveals differences in adaptive immunity towards SARS-CoV-2

Researchers develop broadly neutralizing SARS-CoV-2 ferritin nanoparticle vaccine

Researchers develop broadly neutralizing SARS-CoV-2 ferritin nanoparticle vaccine

Diabetes drug appears to exploit vulnerability of AIDS-causing retrovirus HIV

Diabetes drug appears to exploit vulnerability of AIDS-causing retrovirus HIV

New study may shed light on inflammatory bowel disease

New study may shed light on inflammatory bowel disease

Dual-antigen COVID-19 vaccine elicits humoral and cellular immune responses in mice

Dual-antigen COVID-19 vaccine elicits humoral and cellular immune responses in mice

Could an mRNA vaccine second dose reduce cellular immunity in previously infected individuals?

Could an mRNA vaccine second dose reduce cellular immunity in previously infected individuals?

New guidelines outline key new actions to improve delivery of HIV testing, treatment and care

New guidelines outline key new actions to improve delivery of HIV testing, treatment and care

Single BNT162b2 mRNA dose induces humoral and T cell responses against mutated variants with a history of COVID-19

Single BNT162b2 mRNA dose induces humoral and T cell responses against mutated variants with a history of COVID-19

Circular RNA vaccine shows neutralizing activity against B.1.351 variant

Circular RNA vaccine shows neutralizing activity against B.1.351 variant

New approach to cancer immunotherapy may prevent autoimmunity

New approach to cancer immunotherapy may prevent autoimmunity

Antidiabetic drug could help reduce chronic inflammation in people living with HIV

Antidiabetic drug could help reduce chronic inflammation in people living with HIV

Researchers explore difference in reactions to SARS-CoV-2 infection between children and adults

Researchers explore difference in reactions to SARS-CoV-2 infection between children and adults

COVID-19 is more difficult to diagnose in children and adolescents, finds study

COVID-19 is more difficult to diagnose in children and adolescents, finds study

An overview of the BNT162b2 COVID-19 vaccine by Pfizer-BioNTech

An overview of the BNT162b2 COVID-19 vaccine by Pfizer-BioNTech

Natural virus-induced immunity protective against UK and South African SARS-CoV-2 variants in hamster study

Natural virus-induced immunity protective against UK and South African SARS-CoV-2 variants in hamster study